MedicarePartD.guide

A non-government resource built from CMS public data

Gomekli on Blue Cross MedicareRx Basic (S5715-013)

mirdametinib

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 84 per 28 days.

$10,052.27
Patient pays / month, after deductible
$10,513.52
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

GOMEKLI 2 mg Capsule at a preferred retail pharmacy, from the plan's negotiated price of $40,209.06 for a month. Other covered strengths are listed below.

Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
FormTierPatient pays / monthLimits
GOMEKLI 1 mg Capsule5$10,164.87PA · 168 per 28 days
GOMEKLI 1 mg Tablet, For Suspension5$10,164.87PA · 168 per 28 days
GOMEKLI 2 mg Capsule5$10,052.27PA · 84 per 28 days

Verify with the plan before prescribing or filling. Member services: (888)285-2249. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5715-013